23 0

The Federal Communications Commission will not pursue misinformation complaints against broadcasters who air President Trump’s daily press conferences, the commission announced today. The FCC’s announcement came in response to an emergency petition by the advocacy group Free Press , which had called on the commission to investigate “the spread of false COVID-19 information via broadcast outlets across the United States.” In particular, Free Press alleged that the president was spreading misinformation about the efficacy of the drug hydroxychloroquine, which has been erroneously promoted as a miracle cure for the ongoing pandemic. Commonly prescribed as an antimalarial drug, hydroxychloroq... Full story

6 April